Overview

Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation

Status:
Completed
Trial end date:
1997-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether prucalopride is safe and effective in patients with chronic idiopathic constipation. Hypothesis: At all doses administered prucalopride given once daily for 4 weeks is safe and well tolerated in patients with chronic idiopathic constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Movetis
Treatments:
Prucalopride